Meng Hsien Liu

Title: Meng Hsien Liu: Innovator in Pharmaceutical Chemistry

Introduction

Meng Hsien Liu is a notable inventor based in Toufen, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit NADPH oxidase activity. His work has led to the filing of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Meng Hsien Liu holds 2 patents that reflect his expertise in pharmaceutical compositions. His latest patents include:

1. **NADPH oxidase inhibitors, pharmaceutical composition comprising the same, and application thereof** - This patent discloses a compound of Formula I, which can be a geometric isomer, enantiomer, diastereomer, racemate, atropisomer, pharmaceutically acceptable salt, prodrug, or solvate. The composition described can effectively inhibit NADPH oxidase activity.

2. **Benzene fused heterocyclic derivative and pharmaceutical composition comprising the same** - This patent provides a benzene fused heterocyclic derivative of Formula I, detailing various structural components and their potential applications in pharmaceutical formulations.

Career Highlights

Meng Hsien Liu is currently associated with Taiwan Pharmaceuticals Co., Ltd. His work at the company emphasizes the importance of innovative drug development and the application of his patented compounds in therapeutic settings.

Collaborations

He collaborates with notable colleagues such as Syaulan S Yang and Kuang Yuan Lee, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.

Conclusion

Meng Hsien Liu's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents.